Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

Overview of attention for article published in Trials, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling

Article in Journal of Neuro-Oncology (June 2024)

The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours

Article in Molecular Oncology (April 2024)

Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion

Article in International Journal of Molecular Sciences (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.